CD24 and COVID-19: In addition, Israeli researchers and collaborating teams have demonstrated the safety and efficacy of CD24-loaded EVs in >180 patients with COVID-19-associated ARDS in phase 1b/2a, phase 2b, and compassionate use (NCT04747574, NCT04902183, and NCT05947747)103,189,190.